Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FIBERGRAFT Aeridyan Posterolateral Fusion Study

NCT: NCT07059065 · RECRUITING

NCT IDNCT07059065
StatusRECRUITING
Start Date2025-08-15
Completion2029-12-31
SponsorDePuy Synthes Products, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be conducted at up to 10 clinical sites within the United States.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑